Home > Boards > US Listed > Medical - Drugs > Antares Pharma, Inc. (ATRS)

It wants to break $5, but resistance is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,242
Boards Moderated 3
Alias Born 08/16/16
160x600 placeholder
Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results GlobeNewswire Inc. - 2/25/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 6:29:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 6:28:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2020 6:24:52 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:19:20 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2020 7:08:02 AM
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award GlobeNewswire Inc. - 12/6/2019 7:00:10 AM
Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire Inc. - 11/27/2019 5:51:22 PM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 7:00:00 AM
Antares Pharma Enters Into a Global Development Agreement With Idorsia Pharmaceuticals Ltd. GlobeNewswire Inc. - 11/19/2019 1:00:00 AM
Antares Pharma to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire Inc. - 11/13/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 4:16:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:31:28 AM
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results GlobeNewswire Inc. - 11/5/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:02:13 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/4/2019 7:00:22 AM
Antares Pharma Announces Receipt of Final Payment From Sale of Zomajet™ Needle-Free Delivery System GlobeNewswire Inc. - 10/31/2019 7:00:05 AM
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 10/29/2019 7:00:05 AM
Gazit Globe Offer to Acquire All Minority Shareholder Interests in Subsidiary Atrium Has Not Been Approved GlobeNewswire Inc. - 10/25/2019 10:41:10 AM
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting GlobeNewswire Inc. - 10/24/2019 7:00:05 AM
Gazit Globe Reaffirms its Commitment and Price GlobeNewswire Inc. - 10/11/2019 2:41:57 PM
Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/17/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2019 5:01:34 PM
gi197845   Monday, 12/02/19 12:47:39 PM
Re: None
Post # of 4751 
It wants to break $5, but resistance is stopping it.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist